Javier Molina Infante-rekin lankidetzan egindako argitalpenak (7)

2019

  1. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial

    Gastroenterology, Vol. 157, Núm. 1, pp. 74-86.e15

2016

  1. Response to Ishimura et al.

    American Journal of Gastroenterology

2015

  1. Long-term loss of response in proton pump inhibitor-responsive esophageal eosinophilia is uncommon and influenced by CYP2C19 genotype and rhinoconjunctivitis

    American Journal of Gastroenterology, Vol. 110, Núm. 11, pp. 1567-1575

2014

  1. Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression

    Alimentary Pharmacology and Therapeutics, Vol. 40, Núm. 8, pp. 955-965

2012

  1. Distinguishing eosinophilic esophagitis from gastroesophageal reflux disease upon PPI refractoriness: What about PPI-responsive esophageal eosinophilia?

    Digestion

2010

  1. Acid-suppressive therapy and eosinophilic esophagitis: Friends or foes

    American Journal of Gastroenterology

2009

  1. Omeprazole inhibits IL-4 and IL-13 signaling signal transducer and activator of transcription 6 activation and reduces lung inflammation in murine asthma

    Journal of Allergy and Clinical Immunology